Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.

An α-particle irradiator, enabling high-precision irradiation of cells for in vitro studies, has been constructed. The irradiation source was a (241)Am source, on which well inserts containing cancer cells growing in monolayer were placed.

The total radioactivity, uniformity, and α-particle spectrum were determined by use of HPGe detector, Gafchromic™ dosimetry film, and PIPS(®) detector measurements, respectively. Monte Carlo simulations were used for dosimetry. Three prostate cancer (LNCaP, DU145, PC3) and three pancreatic cancer (Capan-1, Panc-1, BxPC-3) cell lines were irradiated by α-particles to the absorbed doses 0, 0. 5, 1, and 2 Gy. For reference, cells were irradiated using (137)Cs to the absorbed doses 0, 1, 2, 4, 6, 8, and 10 Gy. Radiation sensitivity was estimated using a tetrazolium salt-based colorimetric assay with absorbance measurements at 450 nm. The relative biological effectiveness for α-particles relative to γ-irradiation at 37% cell survival for the LNCaP, DU145, PC3, Capan-1, Panc-1, and BxPC-3 cells was 7. 9 ± 1. 7, 8. 0 ± 0. 8, 7. 0 ± 1. 1, 12. 5 ± 1. 6, 9. 4 ± 0. 9, and 6. 2 ± 0. 7, respectively. The results show the feasibility of constructing a desktop α-particle irradiator as well as indicate that both prostate and pancreatic cancers are good candidates for further studies of α-particle radioimmunotherapy.

Cancer biotherapy & radiopharmaceuticals. 2015 Nov [Epub]

Jenny Nilsson, Monika Posaric Bauden, Jonas M Nilsson, Sven-Erik Strand, Jörgen Elgqvist

1 Department of Radiation Physics, Gothenburg University , Gothenburg, Sweden . , 2 Department of Surgery, Institution of Clinical Sciences, Lund University , Lund, Sweden . , 3 Department of Medical Radiation Physics, Lund University , Malmö, Sweden . , 4 Department of Medical Radiation Physics, Institution of Clinical Sciences, Lund University , Lund, Sweden . , 4 Department of Medical Radiation Physics, Institution of Clinical Sciences, Lund University , Lund, Sweden .

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe